发明申请
US20080221080A1 Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias 审中-公开
治疗混合谱系白血病基因重排的急性淋巴细胞性白血病的方法

  • 专利标题: Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias
  • 专利标题(中): 治疗混合谱系白血病基因重排的急性淋巴细胞性白血病的方法
  • 申请号: US10569708
    申请日: 2003-08-25
  • 公开(公告)号: US20080221080A1
    公开(公告)日: 2008-09-11
  • 发明人: James Douglas GriffinDoriano Fabbro
  • 申请人: James Douglas GriffinDoriano Fabbro
  • 国际申请: PCT/US2003/026629 WO 20030825
  • 主分类号: A61K31/553
  • IPC分类号: A61K31/553 A61P35/02
Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias
摘要:
The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL.
信息查询
0/0